Moxikind CV Survey
Doctor Name
Please enter Doctor Name
Mobile
Please enter Mobile No.
City
Please enter City
1. In your experience, how effective is Amoxycillin-Clavulanic acid in recurrent or resistant ENT infections?
2. In patients with acute bacterial sinusitis, recurrent tonsillitis, or severe otitis media, how effective have you found Amoxycillin-Clavulanic acid 1000 mg BD in achieving faster symptom relief and clinical recovery?
3. How quickly do your patients typically show symptomatic improvement with Amoxycillin-Clavulanic acid?
4. Do you believe contamination-free production of Amoxycillin-Clavulanic acid can improve patient outcomes and reduce treatment failures?
5. Compared with Azithromycin, how would you rate Amoxycillin-Clavulanic acid in reducing recurrence and treatment failure in bacterial ENT infections?
6. In post-operative ENT infections such as tonsillectomy, sinus surgery, or abscess drainage cases, how confident are you in Amoxycillin-Clavulanic acid for providing adequate anaerobic coverage and infection control?
NEXT
Sense2.0 Survey
In a patient with recurrent acute bacterial rhinosinusitis who has received multiple courses of macrolides in the past 6 months, which is the most appropriate reason to prefer Amoxy- Clav acid?
Better antiviral activity
Coverage against β-lactamase producing organisms
Superior antifungal activity
Reduced dosing frequency only
A 62-year-old diabetic patient presents with severe acute otitis media with purulent discharge and facial pain. Which factor makes Amoxycillin-Clavulanic acid a preferred empiric option in this scenario?
Activity against resistant gram-positive and β-lactamase producing pathogens
Excellent antifungal spectrum
Lack of gastrointestinal adverse events
Once-weekly dosing convenience
Which ENT infection scenario is most likely to require high-dose Amoxycillin-Clavulanic acid therapy?
Mild viral pharyngitis
Acute bacterial rhinosinusitis with risk of resistant Streptococcus pneumoniae
Allergic rhinitis
Fungal sinusitis
In chronic suppurative otitis media (CSOM) with suspected mixed aerobic infection, the addition of clavulanic acid primarily helps by:
Increasing renal clearance of amoxycillin
Inhibiting bacterial β-lactamase enzymes
Reducing middle ear inflammation directly
Preventing fungal superinfection
Which of the following difficult-to-treat ENT conditions commonly benefits from Amoxycillin-Clavulanic acid because of polymicrobial involvement?
Allergic rhinitis
Peritonsillar abscess
Vestibular neuritis
Otosclerosis
Which pathogen-related concern most strongly supports the use of Amoxycillin-Clavulanic acid in recurrent acute otitis media?
Presence of MRSA exclusively
β-lactamase producing Haemophilus influenzae and Moraxella catarrhalis
Viral co-infection
Fungal biofilm formation only
In an elderly smoker with acute exacerbation of chronic rhinosinusitis and purulent nasal discharge, Amoxycillin-Clavulanic acid is commonly selected because of its:
Excellent anaerobic and respiratory pathogen coverage
Direct mucolytic activity
Antihistaminic properties
Activity against tuberculosis
Which real-world clinical situation would most justify choosing Amoxycillin-Clavulanic acid over azithromycin in ENT practice?
Suspected bacterial sinusitis with prior macrolide exposure and resistant pathogen risk
Simple allergic sore throat
Viral upper respiratory tract infection
Isolated fungal otitis externa
SUBMIT
START AGAIN
